On March 6, 2019, WIB-Pittsburgh, with special thanks to the Pittsburgh Life Sciences Greenhouse for hosting the event, presented “Women Who Inspire: A Career Panel with Leading Pittsburgh Women”. Ms. Rachel L. Kopper, Director of Business Operations and Finance for Knopp Biosciences LLC and National President and Board Chair for Women In Bio, moderated a panel of professional women representing a variety of careers: Dr. JoAnne Flynn, Professor at the University of Pittsburgh; Dr. Janette Lamb, Director of the University of Pittsburgh Genomics Research Core; Ms. Barbara Militzer, Senior Director of Regulatory Affairs at Mylan Pharmaceuticals; Ms. Nicole Stakleff, partner with Pepper Hamilton LLP; and Dr. Katy Wack, VP of Development of Western Oncolytics.
WIB-Pittsburgh members reconnecting: L-R: Marissa Kuzirian, Technical Specialist at Pepper Hamilton LLP, WIB programming chair; Stephanie Kladakis, Chief Scientific Officer at Carmell Therapeutics; Nicole Ostrowski, Consultant - Enterprise Effectiveness at Highmark; Rachel Kopper, Director, Business Operations & Finance at Knopp Biosciences LLC, WIB National President.
Though each woman’s career journey was unique, common qualities and advice that got them to where they are: find a mentor in the field you are interested in, adopt a growth/grit mindset, be adaptable and open to learning new things, cultivate your soft skills, and always be true to who you are. The event offered ample opportunity for attendees to network and commune with like-minded, career focused professions in the life sciences. Overall, a highly productive and motivating evening!
Women Who Inspire Career panel: Rachel Kopper, career panel moderator Speakers: Dr. JoAnne Flynn, President of the American Association of Immunologists and Professor of Microbiology and Molecular Genetics; Dr. Janette Lamb, Director of the Genomics Research Core at the University of Pittsburgh; Ms. Barbara Militzer is a Senior Director, Regulatory Affairs at Mylan Pharmaceuticals; Ms. Nicole Stakleff, Partner at Pepper Hamilton LLC, non-scientist supporting scientific intellectual property; Dr. Katy Wack, Vice President of Development at Western Oncolytics.